Uncovering the Journey of Genentech’s Susvimo Port Delivery System’s from Challenges to FDA Reapproval
Time: 9:00 am
day: Conference Day One
Details:
- Delving into the process of the reapproval journal
- Uncovering the required modifications to ensure safety
- Exploring clinical data on the efficacy of Susvimo
